Heath Lukatch
DirectoratVaxcyte· In proxies 2023–2025
Heath Lukatch sits on 12 public boards.
Boards1
- VaxcyteDirector · 7 yr on the boardIndependentCompensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- VaxcytePublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +35%
- Inversion Therapeutics Inc.Public company · 1 yr
- Director2025 – Present · 1 yrNo stock prices for these years
- Engrail TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- Acrigen BiosciencesPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Excellergy TherapeuticsPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Magnus Medical, Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- Cargo Therapeutics, Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Bicara TherapeuticsPublic company · 1 yr
- Director2023 – 2024 · 1 yrNo stock prices for these years
- Virsti TherapeuticsPublic company · 2 yr
- Director2021 – 2023 · 2 yrNo stock prices for these years
- Satsuma Pharmaceuticals, Inc.Public company · 7 yr
- Director2016 – 2023 · 7 yrNo stock prices for these years
- Inogen, Inc.Public company · 16 yr
- Director2006 – 2022 · 16 yrNo stock prices for these years
- Engage Therapeutics, Inc.Public company · 3 yr
- Director2017 – 2020 · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?